Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
OptiNose Inc is a US-based specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, utilizes a proprietary breath powered exhalation ... OptiNose Inc is a US-based specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, utilizes a proprietary breath powered exhalation delivery system, to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825. Mehr anzeigen
YARDLEY, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0549 | -11.5578947368 | 0.475 | 0.5 | 0.3914 | 368475 | 0.44334613 | CS |
| 4 | 0.0291 | 7.44245524297 | 0.391 | 0.5766 | 0.391 | 892151 | 0.50763911 | CS |
| 12 | -0.2899 | -40.8309859155 | 0.71 | 0.81 | 0.321 | 765230 | 0.51274991 | CS |
| 26 | -0.7199 | -63.149122807 | 1.14 | 1.3 | 0.321 | 679477 | 0.74366863 | CS |
| 52 | -0.7399 | -63.7844827586 | 1.16 | 2.1 | 0.321 | 730712 | 1.00448849 | CS |
| 156 | -1.2499 | -74.8443113772 | 1.67 | 4.3 | 0.321 | 441779 | 1.38442614 | CS |
| 260 | -8.4299 | -95.2531073446 | 8.85 | 10.07 | 0.321 | 425149 | 2.44103873 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
